Pharvaris N.V. (PHVS) income statement
PHVSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$31.55−0.73 (-2.26%)
Close on Nov 18, 2026Market cap $2.06BP/E –Yield –
Pharvaris N.V. financial ratios
See a number that looks wrong?
Close on Nov 18, 2026Market cap $2.06BP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Returns on capital | |||||||||
| Return on equity | – | – | – | – | -28.4% | -45.4% | – | – | – |
| Return on assets | – | – | – | – | -27.3% | -42.7% | – | – | – |
| Return on tangible assets | – | – | – | – | -27.3% | -42.7% | – | – | – |
| NOPAT | -137.23M | -104.59M | -78.86M | -59.77M | -33.70M | -20.59M | -6.34M | -3.41M | – |
| Cash flow quality | |||||||||
| OCF / Net income | – | – | – | – | 1.04 | 0.83 | – | – | – |
| FCF / OCF | 100.1% | 100.4% | 100.1% | 100.2% | 100.3% | 100.2% | 100.2% | 100.0% | – |
| FCF / Net income | – | – | – | – | 1.05 | 0.83 | – | – | – |
| Unlevered free cash flow | -137.24M | -120.67M | -93.14M | -67.27M | -44.52M | -21.47M | -6.68M | -3.92M | – |
| Levered free cash flow | -137.24M | -120.67M | -93.14M | -67.29M | -44.73M | -21.54M | -6.69M | -3.92M | – |
| Efficiency | |||||||||
| CapEx to OCF | -0.12% | -0.45% | -0.10% | -0.19% | -0.29% | -0.20% | -0.20% | -0.00% | – |
| Leverage | |||||||||
| Assets to equity | 1.11 | 1.09 | 1.04 | 1.12 | 1.03 | 1.06 | 1.10 | – | – |
| Interest coverage | |||||||||
| EBIT / Interest expense | – | – | – | -4,697.51 | -159.47 | -281.92 | -475.51 | -11,352.41 | – |
| Per share | |||||||||
| EPS (basic) | -2.97 | -2.48 | -2.63 | -2.27 | -1.40 | -5.36 | -1.66 | -0.89 | – |
| EPS (diluted) | -2.97 | -2.48 | -2.63 | -2.27 | -1.40 | -5.36 | -1.66 | -0.89 | – |
| Book value per share | 4.59 | 4.96 | 10.00 | 4.44 | 6.74 | 19.75 | 3.85 | 1.02 | – |
| Tangible book value per share | 4.59 | 4.96 | 10.00 | 4.44 | 6.74 | 19.75 | 3.85 | 1.02 | – |
| Cash per share | 4.93 | 5.20 | 10.19 | 4.82 | 6.88 | 20.34 | 4.19 | 1.11 | – |
| Operating cash flow per share | -2.32 | -2.22 | -2.42 | -2.00 | -1.47 | -4.43 | -1.38 | -0.81 | – |
| Free cash flow per share | -2.32 | -2.23 | -2.43 | -2.00 | -1.47 | -4.44 | -1.38 | -0.81 | – |
| CapEx per share | 0.0028 | 0.0100 | 0.0023 | 0.0037 | 0.0043 | 0.0089 | 0.0028 | 0.00 | – |
| Valuation at period end | |||||||||
| Market cap | 1.50B | 735.97M | 942.09M | 342.13M | 69.79M | – | – | – | – |
| Enterprise value | 1.26B | 380.33M | 743.87M | 126.69M | -41.84M | – | – | – | – |
| P/B | 5.5x | 2.7x | 2.5x | 2.3x | 0.3x | – | – | – | – |
| P/TBV | 5.5x | 2.7x | 2.5x | 2.3x | 0.3x | – | – | – | – |
| P/OCF | -10.9x | -6.1x | -10.1x | -5.1x | -1.6x | – | – | – | – |
| EV/EBIT | – | – | – | – | 1.0x | – | – | – | – |
| EV/OCF | -9.2x | -3.2x | -8.0x | -1.9x | 0.9x | – | – | – | – |
| EV/FCF | – | – | – | – | 0.9x | – | – | – | – |
| Earnings yield | – | – | – | – | -61.2% | – | – | – | – |
| FCF yield | -9.2% | -16.4% | -9.9% | -19.7% | -64.1% | – | – | – | – |
| Per employee | |||||||||
| Total employees | 80,000 | 80,000 | 10,000 | 10,000 | 34 | 14 | 14 | 14 | 14 |
| Operating profit per employee | -2.17K | -1.65K | -9.98K | -7.57K | -1.25M | -1.86M | -573.37K | -308.14K | – |
| Net income per employee | – | – | – | – | -1.26M | -1.86M | – | – | – |
| Free cash flow per employee | -1.72K | -1.51K | -9.31K | -6.73K | -1.32M | -1.54M | -477.89K | -279.90K | – |
| Growth | |||||||||
| EBIT 1Y growth | -31.2% | -32.6% | -32.0% | -77.3% | -63.6% | -224.8% | -86.1% | – | – |
| Net income 1Y growth | – | – | – | – | -64.3% | – | – | – | – |
| Diluted EPS 1Y growth | -19.8% | 5.7% | -15.9% | -62.1% | 73.9% | -222.9% | -86.5% | – | – |
| Operating cash flow 1Y growth | -14.1% | -29.1% | -38.5% | -50.6% | -107.4% | -222.0% | -70.4% | – | – |
| Free cash flow 1Y growth | -13.7% | -29.6% | -38.4% | -50.4% | -107.6% | -222.0% | -70.7% | – | – |
| CapEx 1Y growth | -69.4% | 498.0% | -27.6% | -4.4% | 202.6% | 218.9% | – | – | – |
| CapEx 3Y CAGR | 9.8% | 60.5% | 27.9% | 109.7% | – | – | – | – | – |
| CapEx 5Y CAGR | 30.8% | 109.1% | – | – | – | – | – | – | – |
| Total assets 1Y growth | 3.5% | -26.9% | 137.7% | -20.9% | 109.8% | 390.8% | – | – | – |
| Total assets 3Y CAGR | 21.6% | 11.2% | 58.0% | 101.2% | – | – | – | – | – |
| Total assets 5Y CAGR | 24.4% | 69.9% | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.